Диссертация (1139704), страница 34
Текст из файла (страница 34)
Emberton M., Andriole G. L., de la Rosette J., Djavan B., Hoefner K., VelaNavarrete R., Nordling J., Roehrborn C., Schulman C., Teillac P., Tubaro A., Nickel J.C. Benign prostatic hyperplasia: a progressive disease of aging men // Urology. ‒ 2003.‒ T. 61, № 2. ‒ C. 267-73.2. Emberton M., Cornel E. B., Bassi P. F., Fourcade R. O., Gomez J. M., Castro R.Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors andoptions for medical management // Int J Clin Pract. ‒ 2008. ‒ T.
62, № 7. ‒ C. 1076-86.3.Гиперплазияпредстательнойжелезы:Медико-социальныеаспекты,современные технологии хирургического лечения. / Аполихин О.И., КалининскаяА.А. ‒ Москва: Издательский дом Академии Естествознания, 2012. ‒ 164 с.4. World Health Organization launches new initiative to address health needs of arapidly ageing population // Indian J Med Sci. ‒ 2004.
‒ T. 58, № 9. ‒ C. 411-2.5. United Nations. World Population Prospects: The 2015 Revision, Key Findings andAdvance Tables // Department of Economic and Social Affairs, Population Division. ‒2015.6. Djavan B., Nickel J. C., de la Rosette J., Abrams P. The urologist view of BPHprogression: results of an international survey // Eur Urol. ‒ 2002. ‒ T.
41, № 5. ‒ C. 4906.7. EAU Guidelines on Treatment of Non-neurogenic Male LUTS. EAU Guidelines. /S. Gravas (Chair) J. N. C., M.J. Drake, M. Gacci, C. Gratzke, T.R.W. Herrmann, S.Madersbacher, C. Mamoulakis, K.A.O. Tikkinen , Guidelines Associates: M. KaravitakisI. K., S. Malde, V. Sakkalis, R. Umbach ‒ Arnhem, The Netherlands: EAU GuidelinesOffice, 2018. EAU Guidelines.8. Cornu J. N., Ahyai S., Bachmann A., de la Rosette J., Gilling P., Gratzke C., McVaryK., Novara G., Woo H., Madersbacher S. A Systematic Review and Meta-analysis ofFunctional Outcomes and Complications Following Transurethral Procedures for Lower- 220 -Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update // EurUrol.
‒ 2015. ‒ T. 67, № 6. ‒ C. 1066-96.9. Hiraoka Y., Lin T., Tsuboi N., Nakagami Y. Transurethral enucleation of benignprostatic hyperplasia // Nihon Ika Daigaku Zasshi. ‒ 1986. ‒ T. 53, № 2. ‒ C. 212-5.10. Hiraoka Y., Akimoto M. Transurethral enucleation of benign prostatic hyperplasia// J Urol. ‒ 1989. ‒ T. 142, № 5.
‒ C. 1247-50.11. Hiraoka Y. Transurethral endoscopic enucleation of the prostate (EEP) // World JUrol. ‒ 2017. ‒ T. 35, № 10. ‒ C. 1629-1630.12. Gilling P. J., Cass C. B., Cresswell M. D., Malcolm A. R., Fraundorfer M. R. Theuse of the holmium laser in the treatment of benign prostatic hyperplasia // J Endourol. ‒1996. ‒ T. 10, № 5. ‒ C. 459-61.13. Fraundorfer M. R., Gilling P. J.
Holmium:YAG laser enucleation of the prostatecombined with mechanical morcellation: preliminary results // Eur Urol. ‒ 1998. ‒ T. 33,№ 1. ‒ C. 69-72.14. Gilling P. J., Cass C. B., Malcolm A., Cresswell M., Fraundorfer M. R., Kabalin J.N. Holmium laser resection of the prostate versus neodymium:yttrium-aluminum-garnetvisual laser ablation of the prostate: a randomized prospective comparison of twotechniques for laser prostatectomy // Urology. ‒ 1998.
‒ T. 51, № 4. ‒ C. 573-7.15. Gilling P. J., Fraundorfer M. R. Holmium laser prostatectomy: a technique inevolution // Curr Opin Urol. ‒ 1998. ‒ T. 8, № 1. ‒ C. 11-5.16. Herrmann T. R., Georgiou A., Bach T., Gross A. J., Oelke M. Laser treatments ofthe prostate vs TURP/ open prostatectomy: systematic review of urodynamic data //Minerva Urol Nefrol. ‒ 2009. ‒ T. 61, № 3. ‒ C. 309-24.17. Bach T., Xia S. J., Yang Y., Mattioli S., Watson G.
M., Gross A. J., Herrmann T.R. Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? // World J Urol. ‒2010. ‒ T. 28, № 2. ‒ C. 163-8.18. Tiburtius C., Gross A. J., Netsch C. A prospective, randomized comparison of a1940 nm and a 2013 nm thulium: yttrium-aluminum-garnet laser device for ThuliumVapoEnucleation of the prostate (ThuVEP): First results // Indian J Urol. ‒ 2015. ‒ T.
31,№ 1. ‒ C. 47-51.- 221 -19. Kyriazis I., Swiniarski P. P., Jutzi S., Wolters M., Netsch C., Burchardt M.,Liatsikos E., Xia S., Bach T., Gross A. J., Herrmann T. R. Transurethral anatomicalenucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature ona novel surgical approach in the management of benign prostatic enlargement // World JUrol. ‒ 2015. ‒ T. 33, № 4. ‒ C.
525-30.20. Аполихин О.И., Сорокин Д.А., Карпухин И.В., Пучкин А.Б., Семёнычее Д.В.,КочкинА.Д.гиперплазиейДинамикаипрогнозыпредстательнойжелезызаболеваемостивдоброкачественнойнижегородскойобласти//Экспериментальная и клиническая урология ‒2013. ‒ T. 3. ‒ C. 4-7.21.
United Nations. World Population Ageing // Department of Economic and SocialAffairs, Population Division. ‒ 2015.22. Barry M. J. Epidemiology and natural history of benign prostatic hyperplasia //Urol Clin North Am. ‒ 1990. ‒ T. 17, № 3. ‒ C. 495-507.23. Barry M. J. Medical outcomes research and benign prostatic hyperplasia // ProstateSuppl. ‒ 1990. ‒ T. 3. ‒ C. 61-74.24. Sharkey F. E., Dusenbery D.
M., Moyer J. E., Barry J. D. Correlation between stageand grade in prostatic adenocarcinoma: a morphometric study // J Urol. ‒ 1984. ‒ T. 132,№ 3. ‒ C. 602-5.25. Alexander H. L., Moore R. A., Wood W. B., Jr. The Teaching of Tropical Medicine// Science. ‒ 1943. ‒ T. 98, № 2532.
‒ C. 39-40.26. Swyer G. I. Post-natal growth changes in the human prostate // J Anat. ‒ 1944. ‒ T.78, № Pt 4. ‒ C. 130-45.27. Franks L. M. Atrophy and hyperplasia in the prostate proper // J Pathol Bacteriol.‒ 1954. ‒ T. 68, № 2. ‒ C. 617-21.28. Karube K. Study of latent carcinoma of the prostate in the Japanese based onnecropsy material // Tohoku J Exp Med. ‒ 1961.
‒ T. 74. ‒ C. 265-85.29. Haugen O. A., Harbitz T. B. Prostatic weight in elderly men. An analysis in anautopsy series // Acta Pathol Microbiol Scand A. ‒ 1972. ‒ T. 80, № 6. ‒ C. 769-77.30. Harbitz T. B., Haugen O. A. Histology of the prostate in elderly men. A study inan autopsy series // Acta Pathol Microbiol Scand A.
‒ 1972. ‒ T. 80, № 6. ‒ C. 756-68.- 222 -31. Pradhan B. K., Chandra K. Morphogenesis of nodular hyperplasia--prostate // JUrol. ‒ 1975. ‒ T. 113, № 2. ‒ C. 210-3.32. Holund B. Latent prostatic cancer in a consecutive autopsy series // Scand J UrolNephrol. ‒ 1980. ‒ T. 14, № 1. ‒ C. 29-35.33. Rhodes T., Girman C. J., Jacobsen S. J., Roberts R. O., Guess H. A., Lieber M.
M.Longitudinal prostate growth rates during 5 years in randomly selected community men40 to 79 years old // J Urol. ‒ 1999. ‒ T. 161, № 4. ‒ C. 1174-9.34. Bushman W. Etiology, epidemiology, and natural history of benign prostatichyperplasia // Urol Clin North Am. ‒ 2009. ‒ T. 36, № 4. ‒ C.
403-15, v.35. Aus G., Chapple C., Hanus T., Irani J., Lobel B., Loch T., Mitropoulos D., ParsonsK., Plass K., Schmid H. P. The European Association of Urology (EAU) guidelinesmethodology: a critical evaluation // Eur Urol. ‒ 2009. ‒ T. 56, № 5. ‒ C. 859-64.36. Wagg A., Cardozo L., Chapple C., Diaz D. C., de Ridder D., Espuna-Pons M., HaabF., Kelleher C., Kolbl H., Milsom I., Van Kerrebroeck P., Vierhout M., Kirby M.Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?// Int J Clin Pract. ‒ 2008.
‒ T. 62, № 10. ‒ C. 1588-93.37. Garraway W. M., Collins G. N., Lee R. J. High prevalence of benign prostatichypertrophy in the community // Lancet. ‒ 1991. ‒ T. 338, № 8765. ‒ C. 469-71.38. Fowkes F. G., Garraway W. M., Sheehy C. K. The quality of health servicesresearch in medical practice in the United Kingdom // J Epidemiol Community Health. ‒1991. ‒ T. 45, № 2. ‒ C.
102-6.39. Chute C. G., Panser L. A., Girman C. J., Oesterling J. E., Guess H. A., Jacobsen S.J., Lieber M. M. The prevalence of prostatism: a population-based survey of urinarysymptoms // J Urol. ‒ 1993. ‒ T. 150, № 1. ‒ C. 85-9.40. Jolleys J. V., Donovan J. L., Nanchahal K., Peters T. J., Abrams P. Urinarysymptoms in the community: how bothersome are they? // Br J Urol. ‒ 1994. ‒ T. 74, №5. ‒ C. 551-5.41. Roehrborn C. G. Pathology of benign prostatic hyperplasia // Int J Impot Res.
‒2008. ‒ T. 20 Suppl 3. ‒ C. S11-8.- 223 -42. McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology // UrolClin North Am. ‒ 1990. ‒ T. 17, № 3. ‒ C. 477-86.43. Colombel M., Vacherot F., Diez S. G., Fontaine E., Buttyan R., Chopin D. Zonalvariation of apoptosis and proliferation in the normal prostate and in benign prostatichyperplasia // Br J Urol. ‒ 1998. ‒ T. 82, № 3. ‒ C. 380-5.44. Caine M., Raz S., Zeigler M.
Adrenergic and cholinergic receptors in the humanprostate, prostatic capsule and bladder neck // Br J Urol. ‒ 1975. ‒ T. 47, № 2. ‒ C. 193202.45. Elkoushy M. A., Elshal A. M., Elhilali M. M. Holmium laser transurethral incisionof the prostate: Can prostate size predict the long-term outcome? // Can Urol Assoc J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
